Advanced Biomed Inc Income (Loss) Attributable to Parent, before Tax
Advanced Biomed Inc (ADVB) reported Income (Loss) Attributable to Parent, before Tax of $6.25 million for the 9-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossAttributableToParent · last filed 2026-05-15
- Advanced Biomed Inc income (loss) attributable to parent, before tax for the quarter ending 2026-03-31 was -$488.94K, a 140.83% decline year-over-year.
- Advanced Biomed Inc income (loss) attributable to parent, before tax for the quarter ending 2025-03-31 was $1.20M.
| Period end | Income (Loss) Attributable to Parent, before Tax 3 month | Income (Loss) Attributable to Parent, before Tax 6 month | Income (Loss) Attributable to Parent, before Tax 9 month |
|---|---|---|---|
| 2026-03-31 | -$488.94K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-15 | $6.25M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $6.74M 10-Q · filed 2026-02-13 | ||
| 2025-03-31 | $1.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-15 | $1.76M 10-Q · filed 2026-05-15 | |
| 2024-12-31 | $564.61K 10-Q · filed 2026-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |